Schedule 13G ownership disclosure
COCRYSTAL PHARMA INC
Security class unavailable · CUSIP: 19188J300
Event date: 2020-02-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,461,539
- Percent of class
- 7.3500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-20-000076
- Form type
- SC 13G
- Filer
- Cocrystal Pharma, Inc.
- CIK
- CIK 1412486
- Filed
- Feb 27, 2020
- Reporting period
- Feb 27, 2020
- Description
- Schedule 13G beneficial ownership